Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Convertible loan agreement and drawdown

17 Jun 2022 10:30

RNS Number : 2889P
Insig AI Plc
17 June 2022
Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

17 June 2022Β 

Β 

Insig AI plc

("Insig AI" or the "Company")

Convertible Loan Facility Agreement and drawdown

Insig AI plc (AIM: INSG), the data science and machine learning group, is pleased to announce that it has entered into a new convertible loan facility agreement with David Kyte, a long-term shareholder in the Company (the "Agreement"). The key terms are the same as those agreed with Richard Bernstein, non-executive chairman of the Company, announced on 4 May 2022, save that Mr Bernstein is providing a facility of Β£1 million and Mr Kyte a facility of Β£0.5 million.

The loan is unsecured and repayable on or before 31 December 2022. Interest will accrue from the date monies are drawn down under the facility at a rate of 5.0 per cent. per annum, repayable in full at the end of the term.

The loan is redeemable or convertible at the sole discretion of Mr Kyte, at the earlier of the completion of an equity placing by the Company raising not less than Β£2.0m gross proceeds and 31 December 2022.

If converted, the conversion price will be the higher of 35.0 pence per ordinary share of the Company and the prevailing share price at the date of conversion.

Cash drawn down under the Agreement will be in tranches as required by the Company. An initial tranche of Β£0,2 million has been drawn down by the Company.

A second tranche of Β£150,000 has today been drawn down on the convertible loan facility provided by Richard Bernstein, meaning a total of Β£0.4 million has now been drawn down under that facility agreement.

Colm McVeigh, Chief Executive of Insig AI, commented: "I am pleased that David, a long-term supporter of the Company, has approached us to add to our funding options. As we continue to strengthen and deepen our pipeline, this funding will provide further financial flexibility while we continue our discussions with prospects, customers and potential partners."

For further information, please visit www.insg.ai or contact:Β Β 

Insig AI plc

Colm McVeigh (CEO)

Via SEC Newgate

Β 

Zeus (Nominated Adviser & Broker)

David ForemanΒ /Β James HornigoldΒ /Β Danny Phillips

Β 

+44 (0) 20 3829 5000

SEC Newgate (Financial PR)

Robin Tozer / Richard Bicknell

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCUBOKRURUNARR
Date   Source Headline
1st Jun 20267:00 amRNSEquity subscription raising £0.2m and TVR
30th Apr 20267:00 amRNSNon-executive Directors’ Remuneration in Shares
22nd Apr 20267:00 amRNSEquity Subscription, TVR and PDMR Dealing
20th Apr 20267:00 amRNS-RCentral Bank MCP server in action
13th Apr 20267:00 amRNS-RLaunch of Central Bank Model Context Protocol
7th Apr 20267:01 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSPDMR Dealings
1st Apr 20267:00 amRNSTrading update and potential NASDAQ listing
3rd Mar 20267:00 amRNSInsig AI contract win and revenue share agreement
28th Jan 20267:00 amRNSGrant of Share Options
28th Jan 20267:00 amRNSPDMR Dealing
27th Jan 20267:00 amRNSPDMR Dealing
11th Dec 20257:00 amRNSDirector Dealings
9th Dec 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSNew contract with global advisory firm
29th Oct 20257:00 amRNS-RNew client win: new vertical market breakthrough
27th Oct 20257:00 amRNS-RMelloLondon Investor Event
16th Oct 20253:51 pmRNSResult of AGM
16th Oct 20257:00 amRNSTrading update & extended CLNs and warrant terms
8th Oct 202511:43 amRNSEquity fundraise
7th Oct 20257:00 amRNSEquity fundraise
1st Oct 20257:00 amRNSAppointment of Digital Asset Adviser
22nd Sep 20257:00 amRNSSubscription, Director Dealing & TVR
19th Sep 20257:00 amRNSFinal Results, Posting of AR&A and Notice of AGM
30th Jul 20257:00 amRNS-RLaunch of New Website and Corporate Brand Update
24th Jul 20257:00 amRNSDirector Dealing and Total Voting Rights
3rd Jul 20257:00 amRNSAppointment - Strategic & Asset Allocation Adviser
24th Jun 20257:05 amRNS-RAppointment of Business Development Director
24th Jun 20257:00 amRNSEquity Funding, Subscription, TVR & PDMR Dealing
6th Jun 20257:00 amRNSPDMR Dealings
20th May 20257:00 amRNS-RNew client win and additional sales prospects
12th May 20257:00 amRNS-RMello2025 Investor Event
8th May 20257:00 amRNS-RStrategic client win and new GIE product launch
6th May 20258:00 amRNS-RInsig AI & Falcon Windsor publish research re FTSE
29th Apr 20257:00 amRNSTrading Update and New Client Win
15th Apr 20257:00 amRNSPDMR Dealings
27th Mar 20257:00 amRNSPDMR Dealings
26th Mar 20257:00 amRNSPDMR Dealings
25th Mar 20257:00 amRNSPDMR Dealings
24th Mar 20257:03 amRNSTransfer of Share Options
24th Mar 20257:00 amRNSTrading Update, Equity Subscription, Funding & TVR
13th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20259:21 amRNSReplacement: Change of website address
3rd Mar 20257:00 amRNSChange of website address
17th Feb 20257:00 amRNSNew Client Win and Revenue Share Partnership
19th Dec 20247:00 amRNSInterim Results
22nd Nov 20247:00 amRNSNew business win
11th Oct 20247:00 amRNSDirector Dealing
2nd Oct 202411:14 amRNSPDMR Dealing
30th Sep 20242:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.